American Society of Addiction Medicine

Addiction Medicine: Beyond the Abstract

American Society of Addiction Medicine

  • Withdrawal Signs and Symptoms Among Patients Positive for Fentanyl With and Without Xylazine

Withdrawal Signs and Symptoms Among Patients Positive for Fentanyl With and Without Xylazine

Thursday 17th April 2025

Dr. Ryan Alexander discusses his study on fentanyl and xylazine withdrawal symptoms, highlighting key findings and treatment implications.
13 minutes
Informative
Compassionate
Educational
Supportive
Engaging

About this podcast

Addiction Medicine: Beyond the Abstract
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Navigating Intimate Relationships
Nutritional Pathways to Recovery
Links:
Visit site
Episodes:
38 (View all)
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Understanding Withdrawal: Fentanyl and Xylazine Insights

Episode Overview

  • Xylazine affects opioid withdrawal symptoms.
  • Higher systolic blood pressure in xylazine-positive patients.
  • Increased likelihood of self-directed discharges among affected patients.
  • Importance of addressing concurrent withdrawal symptoms.
  • Need for more research on xylazine's long-term effects.
You know, these people are sort of at the rock bottom of their lives and you sort of experience their lives through their stories.
Get ready for an eye-opening conversation on Addiction Medicine: Beyond the Abstract. Dr. Ryan Alexander joins host Dr. Shawn McNeil to share his findings from a recent study on withdrawal symptoms among patients positive for fentanyl with and without xylazine. Dr. Alexander, an addiction medicine specialist and medical director at McNabb Center, dives into how the presence of xylazine impacts opioid withdrawal and the implications for treatment.
He also touches on the broader challenges in addiction medicine, including community stigma and the importance of comprehensive care. You'll hear about the unique effects of xylazine, higher systolic blood pressure in affected patients, and the increased likelihood of self-directed discharges. Dr. Alexander's passion for addiction medicine shines through as he discusses his journey into the field and offers advice for upcoming professionals.
This episode is packed with valuable insights for anyone interested in addiction medicine or those affected by substance use disorders. Don't miss this chance to learn from an expert and understand how new research can shape future treatments.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.